Cohen's SAC Capital Boosts Passive Stake in Incyte (INCY) to 6.4%
In a 13G filing on Incyte Corporation (Nasdaq: INCY), Steven Cohen's SAC Capital disclosed a 6.4% stake (5,458,605 shares) in the company. This is up from the 1,105,000 share stake held at the quarter ended 3/31/08. A 13G indicates a 'passive investment'.
Incyte Corporation operates as a drug discovery and development company, which focuses on developing proprietary small molecule drugs to treat human immunodeficiency virus (HIV), diabetes, oncology, and inflammation diseases.
SAC is a multi-strategy, private asset management firm founded by Steven A. Cohen in 1992 with 9 employees and $25 million in assets under management. As of September 2007, the firm has grown to over 800 employees with approximately $14 billion in assets.
Labels: INCY, Incyte Corporation, SAC Capital, Steven A. Cohen
posted by Lon at 4:24 PM
4 Comments:
I think we should put our comment english where every can able to read views.
Keep up your good work.
Web hosting india
Really awesome post,and keep up your great workfor all of.
Really awesome post,and keep up your great workfor all of. i love very much to it.
Post a Comment
<< Home